Cyber Monday Deal: Up to 60% off InvestingProCLAIM SALE

Why Is Ceragon Networks Surging By 19%? 41 Stocks Moving In Tuesday's Mid-Day Session

Published 28/06/2022, 17:17
© Reuters.  Why Is Ceragon Networks Surging By 19%? 41 Stocks Moving In Tuesday's Mid-Day Session
IXIC
-
CRNT
-

Gainers

  • Agile Therapeutics, Inc. (NASDAQ: AGRX) jumped 88.9% to $2.3986. Agile Therapeutics shares climbed over 10% on Monday amid the Supreme Court overturning Roe V Wade.
  • Kezar Life Sciences, Inc. (NASDAQ: KZR) shares jumped 73.3% to $10.02 after the company announced topline results from the MISSION Phase 2 clinical trial evaluating zetomipzomib.
  • Tuniu Corporation (NASDAQ: TOUR) rose 54.2% to $0.8017 following reports suggesting China will ease some COVID quarantine requirements for international travelers.
  • HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM) gained 47% to $0.8117.
  • Grom Social Enterprises, Inc. (NASDAQ: GROM) surged 31.6% to $0.5800.
  • Endo International plc (NASDAQ: ENDP) climbed 26.3% to $0.4839.
  • Decibel Therapeutics, Inc. (NASDAQ: DBTX) surged 22.7% to $2.75 after reporting data from interim analysis of Phase 1b clinical trial of DB-020.
  • Bird Global, Inc. (NYSE: BRDS) gained 22.5% to $0.5805.
  • Benitec Biopharma Inc. (NASDAQ: BNTC) jumped 22% to $1.8808.
  • Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) gained 19.6% to $0.9796. Petros Pharmaceuticals said it received letter from listing qualifications department of the Nasdaq stock market that the company did not meet the minimum bid price of $1.00/share required for continued listing.
  • Ceragon Networks Ltd. (NASDAQ: CRNT) shares rose 19.1% to $2.49 after Aviat Networks, Inc. proposed to acquire the company for $2.80 per share in cash.
  • The9 Limited (NASDAQ: NCTY) surged 17.3% to $2.3695.
  • Centogene N.V. (NASDAQ: CNTG) gained 16.8% to $2.50. CENTOGENE announced appointment of Miguel Coego Rios as Chief Financial Officer.
  • Sera Prognostics, Inc. (NASDAQ: SERA) surged 16.3% to $2.51.
  • Sutro Biopharma, Inc. (NASDAQ: STRO) gained 16.2% to $5.03. Astellas Pharma and Sutro Biopharma announced a strategic collaboration and licensing agreement focused on the discovery and development of immunostimulatory antibody-drug conjugates (iADC).
  • Trip.com Group Limited (NASDAQ: TCOM) rose 15% to $28.24 after reporting a rise in Q1 sales.
  • Greenwich LifeSciences, Inc. (NASDAQ: GLSI) gained 14% to $10.09.
  • Mesa Royalty Trust (NYSE: MTR) surged 13% to $12.83.
  • SOPHiA GENETICS SA (NASDAQ: SOPH) surged 12.7% to $3.83.
  • Lands' End, Inc. (NASDAQ: LE) gained 11.8% to $12.70. Lands' End announced a $50 million buyback authorization.
  • BiomX Inc. (NYSE: PHGE) jumped 11% to $0.8099 after the company announced a collaboration with Boehringer Ingelheim to identify biomarkers for inflammatory bowel disease.
  • Melco Resorts & Entertainment Limited (NASDAQ: MLCO) rose 10.6% to $6.49 following reports suggesting China will ease quarantine requirements for international travelers.
  • InflaRx N.V. (NASDAQ: IFRX) rose 9.3% to $1.18 after jumping 38% on Monday. InflaRx was granted FDA Orphan Drug Designation on Monday for the treatment of pyoderma gangrenosum.
  • Benitec Biopharma Inc. (NASDAQ: BNTC) gained 7.8% to $1.6599 after jumping 26% on Monday.
  • ENDRA Life Sciences Inc. (NASDAQ: NDRA) rose 7.1% to $0.2410.
Losers
  • Lytus Technologies Holdings PTV. Ltd. (NASDAQ: LYT) shares fell 33.5% to $31.27. Lytus recently announced the closing of initial public offering.
  • Cognyte Software Ltd. (NASDAQ: CGNT) fell 26% to $31.27 after the company reported worse-than-expected Q1 results.
  • Genenta Science S.p.A. (NASDAQ: GNTA) dropped 18.7% to $6.46.
  • IT Tech Packaging, Inc. (NYSE: ITP) shares fell 17.1% to $0.1227. IT Tech Packaging reported a 1-for-10 reverse stock split, effective July 7.
  • Revlon, Inc. (NYSE: REV) fell 16.5% to $5.60. Reliance Industries, in a press release, declined comment on rumor of Revlon takeover interest.
  • Boxed, Inc. (NYSE: BOXD) dipped 14.7% to $2.0550.
  • Aspira Women's Health Inc. (NASDAQ: AWH) dipped 14.3% to $0.5834. Aspira Women's Health shares traded higher on Monday amid the Supreme Court overturning Roe V Wade.
  • Scholar Rock Holding Corporation (NASDAQ: SRRK) dropped 14.2% to $6.30. Scholar Rock Holding shares traded higher on Monday following the purchase of 1,497,490 shares and warrants by a company director, which was disclosed late Friday.
  • Phoenix Motor Inc. (NASDAQ: PEV) declined 12.9% to $5.83.
  • Hillstream BioPharma, Inc. (NASDAQ: HILS) dropped 12.4% to $0.7795. Hillstream BioPharma shares traded higher on Monday after the company announced a collaboration with Sapien Biosciences in cancer treatments to evaluate the synergy of HSB-1216 with immune checkpoint inhibitors.
  • NextPlay Technologies, Inc. (NASDAQ: NXTP) declined 11.2% to $0.3886.
  • Heliogen, Inc. (NYSE: HLGN) dropped 10.6% to $2.76.
  • ToughBuilt Industries, Inc. (NASDAQ: TBLT) fell 10.5% to $2.64 after gaining over 9% on Monday. ToughBuilt recently priced a $6 million offering.
  • Grove Collaborative Holdings, Inc. (NYSE: GROV) dropped 10% to $5.47. Telsey Advisory Group recently initiated coverage on Grove Collaborative with an Outperform rating and announced a price target of $10.
  • NGM Biopharmaceuticals, Inc. (NASDAQ: NGM) declined 9.9% to $13.27.
  • Enerpac Tool Group Corp. (NYSE: EPAC) dropped 7.4% to $18.30 following downbeat Q3 results.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read at Benzinga

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.